gastrointestinal funding
18 open opportunities tagged gastrointestinal, across federal agencies and private foundations. Sorted by deadline.
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
S. technology development and commercialization.
6 review criteria on fileSBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
S. technology development and commercialization.
7 review criteria on fileAtopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
Research Objectives Atopic Dermatitis (AD) is a chronic inflammatory pruritic skin disease that affects approximately 11% of children and up to 9% of adults in the United States.
13 review criteria on fileSpecialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE).
5 review criteria on fileSilvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
Program Objective This Notice of Funding Opportunity (NOFO) invites applications for Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs) to support research related to digestive and/or liver diseases and their complications.
12 review criteria on fileSingle Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)
This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite application(s) from eligible organization(s) to apply. Please see Section III.
7 review criteria on filePriority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that aligns with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR).
3 review criteria on fileStimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Aging (NIA), and the National Heart, Lung, and Blood…
3 review criteria on fileInterventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
). This NOFO is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25, 2025.
3 review criteria on fileOptimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
Purpose This Notice of Funding Opportunity (NOFO) invites applications for a Research Coordinating Center (RCC) to participate in a new consortium with clinical centers that will test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use.
7 review criteria on fileOptimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
Purpose This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use.), and quality of life and be feasible to implement in clinical care settings.
3 review criteria on fileINCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)
This Notice of Funding Opportunity (NOFO) invites researchers to submit applications for support of new exploratory and developmental research projects that address important gaps in Down syndrome research.
3 review criteria on fileINCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)
The INCLUDE Transformative Research Award Program supports collaborative investigative teams or individual scientists who propose unusually innovative research projects, which, if successful, would have a major impact in understanding the biology of Down syndrome or related co-occurring conditions, or development of new treatments for…
3 review criteria on fileINCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)
Purpose The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome.
3 review criteria on fileLimited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announces a limited-competition program that provides NIDDK-supported K01, K08, K23, and K25 recipients the opportunity to apply for Small Grant (R03) support during the latter years of the award period of their K award.
3 review criteria on filePRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Purpose Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) NOFOs seek to spur on the development of innovative, reliable, cost-effective, and sustainable multimodal AI-based clinical decision support (CDS) tools with the potential for transformational impact.
3 review criteria on fileNutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) invites applications for Nutrition Obesity Research Center (NORC) grants to support research in nutrition and/or obesity.
13 review criteria on fileDiabetes Research Centers (P30 Clinical Trial Optional)
Background According to the CDC, the prevalence of diabetes mellitus in the United States continues to rise over time.6% of the US Population) and about twice that prevalence in those over 65.
9 review criteria on fileSee which gastrointestinal opportunities fit your work
An account is free and shows the full announcement, the review criteria reviewers score you against, and whether you are actually eligible — including the windows that close before the deadline does.
No card required.